Lutein-Lux Eye to Z
Natural health product licensed in Canada
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 500 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (25 mg a day). The EFSA reference covers total daily intake, from food and supplements.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 250 milligramme | 500,000 µg |
| Vitamine E Source : Acétate de d-alpha tocophéryle | 134 mg AT | Not calculated |
| Zinc Source : Gluconate de zinc | 25 milligramme | 50,000 µg |
| Cuivre Source : Produit de chélation de cuivre (II) et de protéine végétale hydrolysée (PVH) | 1 milligramme | 2,000 µg |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Tagetes erecta - Fleur Potency : 0.25 milligramme Zeaxanthin | 5 milligramme | Not calculated |
| Lycopène Source : Solanum lycopersicum - fruit | 5 milligramme | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Capsicum frutescens - fruit | 5 milligramme | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone-3-rutinoside Source : Solanum lycopersicum - fruit | 5 milligramme | Not calculated |
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 6.8 Grammes Potency : 36 % Anthocyanosides | 170 milligramme | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 375 milligramme Potency : 80 % Proanthocyanidins | 12.5 milligramme | Not calculated |
| Vitamine E Source : Acétate de d-alpha tocophéryle | 200 UI | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Cellulose microcristalline, Acide stéarique, Stéarate de magnésium, Phosphate dicalcique, Gel de silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Source of/An antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Helps to prevent vitamin C deficiency. Source of/An antioxidant for the maintenance of good health. Helps to prevent vitamin E deficiency. A factor in the maintenance of good health. Helps to maintain/support eyesight in certain conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. An antioxidant. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you are allergic to plants of the Asteraceae/ Compositae/Daisy family.
- Précautions et mises en garde
Consult a health care practitioner if you: are experiencing decreased vision; have cancer, diabetes or cardiovascular disease. Consult a health care practitioner if symptoms worsen.
Product record
- Licence holder
- Jensens Labs Inc.
- NPN or DIN-HM
- 80083635
- Status
- Active licence
- Licence date
- 6 March 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80083635
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Lutein-Lux Eye to Z (Jensens Labs Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80083635-lutein-lux-eye-to-z, updated 6 March 2018.